Biovaxys Technology Corp
OTC:BVAXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biovaxys Technology Corp
OTC:BVAXF
|
CA |
|
LVMH Moet Hennessy Louis Vuitton SE
OTC:LVMHF
|
FR |
|
B
|
Banco Internacional SA
SGO:BINT
|
CL |
Bankruptcy Probability
Biovaxys Technology Corp's probability of bankruptcy is 5%, signalling a meaningful chance of default. The solvency score is 30/100 — a sign of moderate financial strength.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biovaxys Technology Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
B
|
Biovaxys Technology Corp
CNSX:BIOV
|
3.1m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
229.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
437.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BeOne Medicines AG
SSE:688235
|
231.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Genmab A/S
CSE:GMAB
|
156.2B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Biontech SE
NASDAQ:BNTX
|
22.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
17.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| LU |
|
Eurofins Scientific SE
PAR:ERF
|
13.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
15.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biovaxys Technology Corp's probability of bankruptcy is 5%, signalling a meaningful chance of default.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biovaxys Technology Corp has total debt of 133.7k CAD. This includes both short-term (133.7k CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.